Literature DB >> 2368435

Clinical significance of associated nodular lesions of the adrenal in patients with aldosteronoma.

Y Ito1, Y Fujimoto, T Obara, T Kodama.   

Abstract

Thirty-seven patients with primary aldosteronism were treated by unilateral total adrenalectomy during a 7-year period (1981-1987). The 37 patients were classified into 3 groups on the basis of adrenal pathology: unilateral solitary adenoma, 23 cases (group 1); unilateral adenomas, 3 cases (group 2); and adenoma with multiple macro- or microscopic nodules, 11 cases (group 3). The preoperative conditions of the patients (age, duration of hypertension, plasma renin activity, plasma aldosterone concentration, and serum potassium concentration), postoperative sequential changes of hormone levels, and outcome of hypertension were compared among the groups in order to determine whether the differences of adrenal pathology would affect the postoperative course. The preoperative parameters excluding age at surgery did not differ significantly among the 3 groups. The mean age in group 3, however, was slightly higher than in groups 1 and 2 (47.8 versus 42.8 versus 42.7 years). Postoperative hormonal changes were also similar, particularly in groups 1 and 3, staying within the normal range throughout the follow-up period (mean, 31 months; range, 3-86 months). However, postoperative improvement of hypertension showed marked differences, being significantly retarded in patients with multinodular lesions (group 3), about half of whom remained hypertensive even after 1 year. Nodular lesions other than adenoma(s) were, therefore, thought not to contribute to hormonal excess but to result from intractable hypertension.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2368435     DOI: 10.1007/bf01658518

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  13 in total

1.  SUPPRESSION OF PLASMA RENIN ACTIVITY IN PRIMARY ALDOSTERONISM.

Authors:  J W CONN; E L COHEN; D R ROVNER
Journal:  JAMA       Date:  1964-10-19       Impact factor: 56.272

2.  Primary aldosteronism: diagnosis, localization, and treatment.

Authors:  M H Weinberger; C E Grim; J W Hollifield; D C Kem; A Ganguly; N J Kramer; H Y Yune; H Wellman; J P Donohue
Journal:  Ann Intern Med       Date:  1979-03       Impact factor: 25.391

3.  Adrenocortical nodular hyperplasia: the ageing adrenal.

Authors:  J W Dobbie
Journal:  J Pathol       Date:  1969-09       Impact factor: 7.996

4.  Primary aldosteronism. Clinical management.

Authors:  C S Grant; P Carpenter; J A van Heerden; B Hamberger
Journal:  Arch Surg       Date:  1984-05

5.  The treatment of low-renin ("primary") hyperaldosteronism.

Authors:  J B Ferriss; D G Beevers; K Boddy; J J Brown; D L Davies; R Fraser; D Kremer; A F Lever; J I Robertson
Journal:  Am Heart J       Date:  1978-07       Impact factor: 4.749

6.  Results of adrenal surgery in patients with hypertension, aldosterone excess, and low plasma renin concentration.

Authors:  J B Ferriss; J J Brown; R Fraser; E Haywood; D L Davies; A W Kay; A F Lever; J I Robertson; K Owen; W S Peart
Journal:  Br Med J       Date:  1975-01-18

Review 7.  The nodular adrenal.

Authors:  A M Neville
Journal:  Invest Cell Pathol       Date:  1978 Jan-Mar

8.  Primary aldosteronism. A follow-up study of 28 cases of surgically treated aldosterone-producing adenomas.

Authors:  P E Lins; U Adamson
Journal:  Acta Med Scand       Date:  1987

9.  Selection of patients and operative approach in primary aldosteronism.

Authors:  T K Hunt; M Schambelan; E G Biglieri
Journal:  Ann Surg       Date:  1975-10       Impact factor: 12.969

View more
  7 in total

Review 1.  [Recurrent operations on the adrenal glands].

Authors:  M Brauckhoff; H Dralle
Journal:  Chirurg       Date:  2005-03       Impact factor: 0.955

Review 2.  Primary aldosteronism. Results of surgical treatment.

Authors:  C Y Lo; P C Tam; A W Kung; K S Lam; J Wong
Journal:  Ann Surg       Date:  1996-08       Impact factor: 12.969

3.  Primary Aldosteronism: Does Underlying Pathology Impact Clinical Presentation and Outcomes Following Unilateral Adrenalectomy?

Authors:  Omair A Shariq; Kabir Mehta; Geoffrey B Thompson; Melanie L Lyden; David R Farley; Irina Bancos; Benzon M Dy; William F Young; Travis J McKenzie
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

4.  Surgical treatment of primary hyperaldosteronism.

Authors:  R J Weigel; S A Wells; J C Gunnells; G S Leight
Journal:  Ann Surg       Date:  1994-04       Impact factor: 12.969

5.  Adrenalectomy in primary aldosteronism: a long-term follow-up study in 52 patients.

Authors:  G Favia; F Lumachi; V Scarpa; D F D'Amico
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

6.  Changes in urinary kallikrein excretion and plasma natriuretic factor in a patient with primary aldosteronism with special reference to adrenal histology.

Authors:  S Hayami; T Nakada; H Kakizaki; T Yagisawa; H Kaneko; Y Iijima; H Obata; M Miura
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

Review 7.  Partial adrenalectomy in patients with multiple adrenal tumors.

Authors:  C P Pavlovich; W M Linehan; M M Walther
Journal:  Curr Urol Rep       Date:  2001-02       Impact factor: 2.862

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.